CC

Casdin Capital Portfolio holdings

AUM $1.1B
1-Year Return 24.98%
This Quarter Return
+44.82%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
AUM
$3.36B
AUM Growth
+$1.13B
Cap. Flow
+$516M
Cap. Flow %
15.36%
Top 10 Hldgs %
62.51%
Holding
56
New
11
Increased
11
Reduced
2
Closed
6
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GBT
26
DELISTED
Global Blood Therapeutics, Inc.
GBT
$35.1M 1.04%
810,000
+415,000
+105% +$18M
FDMT icon
27
4D Molecular Therapeutics
FDMT
$314M
$32.4M 0.96%
+780,555
New +$32.4M
DNTH icon
28
Dianthus Therapeutics
DNTH
$1.51B
$26.2M 0.78%
209,127
ZLAB icon
29
Zai Lab
ZLAB
$3.6B
$25.7M 0.76%
190,000
IOVA icon
30
Iovance Biotherapeutics
IOVA
$854M
$25.5M 0.76%
550,000
+260,000
+90% +$12.1M
ALEC icon
31
Alector
ALEC
$286M
$25M 0.74%
1,650,000
ALLO icon
32
Allogene Therapeutics
ALLO
$262M
$23.9M 0.71%
945,000
MASS icon
33
908 Devices
MASS
$227M
$23.2M 0.69%
+406,502
New +$23.2M
TSHA icon
34
Taysha Gene Therapies
TSHA
$824M
$21.8M 0.65%
820,440
ORIC icon
35
Oric Pharmaceuticals
ORIC
$1.06B
$20.4M 0.6%
601,515
+350,000
+139% +$11.8M
CELL
36
DELISTED
PhenomeX Inc. Common Stock
CELL
$17.9M 0.53%
200,000
KRON
37
DELISTED
Kronos Bio
KRON
$17.4M 0.52%
+583,436
New +$17.4M
SGMO icon
38
Sangamo Therapeutics
SGMO
$154M
$16.9M 0.5%
1,080,000
FULC icon
39
Fulcrum Therapeutics
FULC
$395M
$14.5M 0.43%
1,241,176
-200,000
-14% -$2.34M
SNDX icon
40
Syndax Pharmaceuticals
SNDX
$1.3B
$10M 0.3%
+450,000
New +$10M
BDTX icon
41
Black Diamond Therapeutics
BDTX
$186M
$9.28M 0.27%
289,395
TPTX
42
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$9.14M 0.27%
75,000
SEER icon
43
Seer Inc
SEER
$116M
$8.42M 0.25%
+150,000
New +$8.42M
ABCL icon
44
AbCellera Biologics
ABCL
$1.36B
$8.05M 0.24%
+200,000
New +$8.05M
DYN icon
45
Dyne Therapeutics
DYN
$1.89B
$7.77M 0.23%
370,000
STOK icon
46
Stoke Therapeutics
STOK
$1.28B
$7.43M 0.22%
120,000
FHTX icon
47
Foghorn Therapeutics
FHTX
$283M
$4.38M 0.13%
+216,216
New +$4.38M
BMY.RT
48
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$4.31M 0.13%
6,250,000
CDAK
49
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$2.48M 0.07%
+76,688
New +$2.48M
CCCC icon
50
C4 Therapeutics
CCCC
$242M
$1.33M 0.04%
+40,000
New +$1.33M